ATC Group: L01A Alkylating agents

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of L01A in the ATC hierarchy

Level Code Title
1 L Antineoplastic and immunomodulating agents
2 L01 Antineoplastic agents
3 L01A Alkylating agents

Group L01A contents

Code Title
L01AA Nitrogen mustard analogues
L01AB Alkyl sulfonates
L01AC Ethylene imines
L01AD Nitrosoureas
L01AG Epoxides
L01AX Other alkylating agents

Active ingredients in L01A

Active Ingredient Description
Bendamustine

Bendamustine is an alkylating antitumour agent with unique activity. The antineoplastic and cytocidal effect of bendamustine is based essentially on a cross-linking of DNA single and double strands by alkylation. As a result, DNA matrix functions and DNA synthesis and repair are impaired.

Busulfan

Busulfan is a potent cytotoxic agent and a bifunctional alkylating agent. In aqueous media, release of the methanesulphonate groups produces carbonium ions which can alkylate DNA, thought to be an important biological mechanism for its cytotoxic effect.

Carboquone

Carboquone is an anticancer alkylating agent, having chemical structure, 2,5-bis-(1-aziridinyl)3(2-carbamoyloxy-1-methoxyethyl)-6-methyl- 1,4- benzoquinone. The antitumor efficacies of carboquone were reported as excellent, however, the side effects are considerably strong.

Carmustine

Carmustine is a cell-cycle phase nonspecific antineoplastic agent of the nitrosourea type. As an alkylating agent, it can alkylate reactive sites on nucleoproteins, thus interfering with DNA and RNA synthesis and DNA repair. In addition, carmustine is known to carbamoylate lysine residues on proteins causing irreversible inactivation of enzymes including glutathione reductase.

Chlorambucil

Chlorambucil is an aromatic nitrogen mustard derivative which acts as a bifunctional alkylating agent. In addition to interference with DNA replication, chlorambucil induces cellular apoptosis via the accumulation of cytosolic p53 and subsequent activation of an apoptosis promoter.

Chlormethine

Chlormethine is a bifunctional alkylating agent that inhibits rapidly proliferating cells. It works by binding to DNA, crosslinking two strands and preventing cell duplication. It binds to the N7 nitrogen on the DNA base guanine. It has been derivatized into the estrogen analogue estramustine phosphate, used to treat prostate cancer.

Cyclophosphamide

Cyclophosphamide has been demonstrated to have a cytostatic effect in many tumour types. The active metabolites of cyclophosphamide are alkylating agents which transfer alkyl groups to DNA during the process of cell division, thus preventing normal synthesis of DNA.

Dacarbazine

Dacarbazine is a cytostatic agent. The antineoplastic effect is due to an inhibition of cell growth which is independent of the cell cycle and due to an inhibition of DNA synthesis.

Fotemustine

Fotemustine is a chloroethylating nitrosourea with antineoplastic activity. Fotemustine alkylates guanine by forming chloroethyl adducts at the 6 position of guanine, resulting in N1-guanine and N3-cytosine cross linkages, inhibition of DNA synthesis, cell cycle arrest, and finally apoptosis. This agent is lipophilic and crosses the blood-brain barrier.

Ifosfamide

Ifosfamide is an antineoplastic, a cytotoxic alkylating agent. It is a prodrug and shows no in vitro cytotoxic activity until activated by microsomal enzymes. The cytotoxic activity of ifosfamide (alkylation of the nucleophilic centres in the cells) is associated with the activated oxazaphosphorine ring hydroxylated at the C4 atom which interacts with DNA-DNA cross linking. This activity manifests itself by blocking the late S and early G2 phases of the cell cycle.

Lomustine

Lomustine’s mode of action is believed to be partly as an alkylating agent and partly by inhibition of several steps in the synthesis of nucleic acid and inhibition of the repair of single strand breaks in DNA chains.

Melphalan

Melphalan is a bifunctional alkylating agent. Formation of carbonium intermediates from each of the two bis-2-chloroethyl groups enables alkylation through covalent binding with the 7-nitrogen of guanine on DNA, cross-linking the two DNA strands and thereby preventing cell replication.

Streptozocin
Temozolomide

Temozolomide is a triazene, which undergoes rapid chemical conversion at physiologic pH to the active monomethyl triazenoimidazole carboxamide (MTIC). The cytotoxicity of MTIC is thought to be due primarily to alkylation at the O6 position of guanine with additional alkylation also occurring at the N7 position. Cytotoxic lesions that develop subsequently are thought to involve aberrant repair of the methyl adduct.

Thiotepa

Thiotepa is a polyfunctional cytotoxic agent related chemically and pharmacologically to the nitrogen mustard. The radiomimetic action of thiotepa is believed to occur through the release of ethylene imine radicals that, as in the case of irradiation therapy, disrupt the bonds of DNA, e.g. by alkylation of guanine at the N-7, breaking the linkage between the purine base and the sugar and liberating alkylated guanine.

Treosulfan

Treosulfan is a prodrug of a bifunctional alkylating agent with cytotoxic activity to haematopoietic precursor cells. The activity of treosulfan is due to the spontaneous conversion into a mono-epoxide intermediate and L-diepoxybutan. Treosulfan has a broad antineoplastic and antileukaemic activity.

Related product monographs

Title Information Source Document Type  
ALKERAN Health Products Regulatory Authority (IE) MPI, EU: SmPC
BENDAMUSTINE HYDROCHLORIDE ACCORD Powder for concentrate for solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BUSILVEX Concentrate for solution European Medicines Agency (EU) MPI, EU: SmPC
BUSULFAN Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BUSULFEX Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
CARMUSTINE OBVIUS Powder and solvent for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC
CHLORAMBUCIL Film-coated tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DACARBAZINE Powder for solution for injection or infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
GLIADEL Implant Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
IFEX Powder for solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
LEDAGA Gel European Medicines Agency (EU) MPI, EU: SmPC
LEUKERAN Tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MELPHALAN Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MELPHALAN Powder and solvent for solution for injection/infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MYLERAN Film-coated tablet FDA, National Drug Code (US) MPI, US: SPL/Old
PEPAXTI Powder for concentrate for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC
PHELINUN Powder and solvent for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC
RIBOMUSTIN Powder for solution for infusion Marketing Authorisation Holder MPI, EU: SmPC
TEMODAL Hard capsule European Medicines Agency (EU) MPI, EU: SmPC
TEMODAL Powder for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC
TEPADINA Powder for concentrate for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC
TREANDA Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
TRECONDI Powder for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC
ZANOSAR Powder for concentrate for solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC